Preservation of sexual potency in prostatic cancer patients after pelvic lymphadenectomy and retropubic 125I implantation.
Sexual histories were obtained from 51 patients (average age 67.7 years) with prostatic cancer and their spouses before and after pelvic lymphadenectomy and retropubic 125iodine implantation. Sexual potency was retained in 40 of the 41 patients who were sexually active preoperatively. Ten patients were sexually inactive preoperatively: 4 with diminished potency and 6 with complete erectile impotence. Sexual dysfunction was most often psychogenic in origin. At 6 months 5 of these patients had resumed satisfactory sexual intercourse as a result of reassurance, encouragement and education of remaining sexual potential. No patient suffered complete erectile impotence as a result of the procedure.
D000368:Aged; D003376:Counseling; D007172:Erectile Dysfunction / Q000517:prevention & control; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage*; D008197:Lymph Node Excision; D008297:Male; D008875:Middle Aged; D010388:Pelvis; D011467:Prostate; D011471:Prostatic Neoplasms / Q000532:radiotherapy / Q000628:therapy*; D012725:Sexual Behavior
D007457:Iodine Radioisotopes